Major partnerships in the cell and gene therapy industry in 2020, by upfront payment

This statistic shows the major corporate partnerships made in the cell and gene therapy industry during 2020, by upfront payment. In that year, Biogen and Sangamo signed the highest upfront agreement for 350 million U.S. dollars.

Major corporate partnerships in the global cell and gene therapy industry in 2020, by upfront payment

Loading statistic...
You need to log in to download this statistic
Register for free
Already a member?
Log in
Show detailed source information?
Register for free
Already a member?
Log in
Source

Release date

January 2021

Region

Worldwide

Survey time period

2020

Statista Accounts: Access All Statistics. Starting from $468 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.

Single Account
The ideal entry-level account for individual users
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$59 $39 / Month *
in the first 12 months
Corporate Account
Full access

Corporate solution including all features.

* Prices do not include sales tax.

Statistics on "Cell and gene therapy"

Statista Accounts: Access All Statistics. Starting from $468 / Year
Learn more about how Statista can support your business.